Pure Global AI
ANVISA registration 10387650138Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 10387650138CAPRICORN TECHNOLOGIES DO BRASIL LTDADXGEN CORP.Risk Class II
Verified
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
View exact technical-name matches →
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
Kit para Teste HbA1c Epithod®
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10387650138
Process Number
25351021554202396
CNPJ
02823683000102
Company information
Registration Holder
CAPRICORN TECHNOLOGIES DO BRASIL LTDA
Manufacturer
DXGEN CORP.
Manufacturing Country
South Korea
PT: CORÉIA DO SUL
Dates and status
Publication Date
Jan 30, 2023
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10387650138 and manufactured by DXGEN CORP.. The registration is held by CAPRICORN TECHNOLOGIES DO BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.